Log in | Register

What’s new in antimicrobial use and resistance in critically ill patients?

Matteo Bassetti| David P. Nicolau| Thierry Calandra
What's New in Intensive Care
Volume 40, Issue 3 / March , 2014

Pages 422 - 426

No abstract available.

References

  1. Quenot JP, Binquet C, Kara F et al (2013) The epidemiology of septic shock in French intensive care units: the prospective multicenter cohort EPISS study. Crit Care 17(2):R65
    • View reference on PubMed
    • View reference on publisher's website
  2. Dellinger RP, Levy MM, Rhodes A et al (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39(2):165–228
  3. Tabah A, Koulenti D, Laupland K et al (2012) Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study. Intensive Care Med 38(6):940–949
  4. European Antimicrobial Resistance Surveillance Network (EARS-Net) (2013) Antimicrobial resistance surveillance in Europe 2012. Surveillance report. http://www.ecdc.europa.eu/en/activities/surveillance/EARS-Net. Accessed 1 Dec 2013
  5. Kontopidou F, Giamarellou H, Katerelos P et al (2013) Infections caused by carbapenem-resistant Klebsiella pneumoniae among patients in intensive care units in Greece: a multi-centre study on clinical outcome and therapeutic options. Clin Microbiol Infect. doi:10.1111/1469-0691.12341
    • View reference on PubMed
  6. Oostdijk EA, Smits L, de Smet AM, Leverstein-van Hall MA, Kesecioglu J, Bonten MJ (2013) Colistin resistance in Gram-negative bacteria during prophylactic topical colistin use in intensive care units. Intensive Care Med 38(12):1930–1945
  7. Mohamed AF, Karaiskos I, Plachouras D et al (2012) Application of a loading dose of colistin methanesulfonate in critically ill patients: population pharmacokinetics, protein binding, and prediction of bacterial kill. Antimicrob Agents Chemother 56(8):4241–4249
    • View reference on PubMed
    • View reference on publisher's website
  8. Woods CJ, Chowdhury A, Patel VM, Shorr AF (2012) Impact of vancomycin minimum inhibitory concentration on mortality among critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 33(12):1246–1249
    • View reference on PubMed
    • View reference on publisher's website
  9. Murray KP, Zhao JJ, Davis SL, Kullar R, Kaye KS, Lephart P, Rybak MJ (2013) Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study. Clin Infect Dis 56(11):1562–1569
    • View reference on PubMed
    • View reference on publisher's website
  10. Falcone M, Russo A, Venditti M, Novelli A, Pai MP (2013) Considerations for higher doses of daptomycin in critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 57:1568–1576
    • View reference on PubMed
    • View reference on publisher's website
  11. Aliberti S, Cilloniz C, Chalmers JD et al (2013) Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective. Thorax 68(11):997–999
    • View reference on PubMed
    • View reference on publisher's website
  12. Garnacho-Montero J, Gutiérrez-Pizarraya A, Escoresca-Ortega A et al (2013) De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock. Intensive Care Med 39:2237
  13. Bouza E, Granda MJ, Hortal J, Barrio JM, Cercenado E, Muñoz P (2013) Pre-emptive broad-spectrum treatment for ventilator-associated pneumonia in high-risk patients. Intensive Care Med 39(9):1547–1555
  14. Bauer KA, West JE, O’Brien JM, Goff DA (2013) Extended-infusion cefepime reduces mortality in patients with Pseudomonas aeruginosa infections. Antimicrob Agents Chemother 57:2907–2912
    • View reference on PubMed
    • View reference on publisher's website
  15. Dulhunty JM, Roberts JA, Davis JS et al (2013) Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial. Clin Infect Dis 56(2):236–244
    • View reference on PubMed
    • View reference on publisher's website
  16. Arnold HM, Hollands JM, Skrupky LP et al (2013) Prolonged infusion antibiotics for suspected Gram-negative infections in the ICU: a before–after study. Ann Pharmacother 47:170–180
    • View reference on PubMed
    • View reference on publisher's website
  17. Wilde AM, Nailor MD, Nicolau DP, Kuti JL (2012) Inappropriate antibiotic use due to decreased compliance with a ventilator-associated pneumonia computerized clinical pathway: implications for continuing education and prospective feedback. Pharmacotherapy 32(8):755–763
    • View reference on PubMed
    • View reference on publisher's website
  18. Matthaiou DK, Ntani G, Kontogiorgi M, Poulakou G, Armaganidis A, Dimopoulos G (2012) An ESICM systematic review and meta-analysis of procalcitonin-guided antibiotic therapy algorithms in adult critically ill patients. Intensive Care Med 38(12):1930–1945
  19. Blot SI, Taccone FS, Van den Abeele AM et al (2012) A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. Am J Respir Crit Care Med 186:56–64
    • View reference on PubMed
    • View reference on publisher's website
  20. Tissot F, Lamoth F, Hauser PM et al (2013) Beta-Glucan antigenemia anticipates diagnosis of blood culture-negative intra-abdominal candidiasis. Am J Respir Crit Care Med 188(9):1100–1109
    • View reference on PubMed
    • View reference on publisher's website
  21. León C, Ruiz-Santana S, Saavedra P et al (2012) Value of β-d-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions. Intensive Care Med 38(8):1315–1325
  22. Neely LA, Audeh M, Phung NA et al (2013) T2 magnetic resonance enables nanoparticle-mediated rapid detection of candidemia in whole blood. Sci Transl Med 5:182ra154
  23. Ostrosky-Zeichner L, Shoham S, Vazquez J et al (2011) MSG-01 a multicenter, randomized, double-blind, placebo controlled trial of caspofungin (CAS) prophylaxis vs placebo followed by pre-emptive therapy for invasive candidiasis (IC) in high-risk adults in the critical care setting. Preliminary results. Annu Sci Meet SHEA 2011. Dallas, TX, April 1–4, 2011
  24. Andes DR, Safdar N, Baddley JW, Playford G, Reboli AC, Rex JH, Sobel JD, Pappas PG, Kullberg BJ (2012) Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis 54:1110–1122
    • View reference on PubMed
    • View reference on publisher's website
  25. Cornely OA, Bassetti M, Calandra T et al (2012) ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect 18(Suppl 7):19–26
    • View reference on PubMed
    • View reference on publisher's website
  26. Bassetti M, Marchetti M, Chakrabarti A et al (2013) A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. Intensive Care Med 39(12):2092–2106

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement